Justin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
In September 2022, an updated COVID-19 booster shot was released, intended to give those previously vaccinated against the virus enhanced immunity. Despite urging from the Centers for Disease Control and Prevention and other leading medical agencies, a minority of Americans got the shot.
This week, researchers from the University of Arizona released findings as to why so many Americans who had gotten at least one dose of the primary series of the vaccine opted not to get a booster. The results indicated there were many reasons why. The No. 1 reason cited was a prior COVID-19 infection , which was followed by concerns over side effects . About 28.6% said they believed the booster would not provide added protection, while 23.
The CDC recommended the shots for those ages 5 and up who already had received their primary series of shots. The shots released in September 2022 were considered bivalent, which provided antibodies against early strains of the virus and the omicron variant. "The updated COVID-19 boosters are formulated to better protect against the most recently circulating COVID-19 variant," CDC Director Rochelle Walensky said in September 2022.
The updated mRNA vaccines are approved for individuals 12 years of age and older and are authorized under emergency use for individuals 6 months through 11 years of age.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Experts break down why Americans are getting tired of ‘woke’ capitalismConsumer experts explain the reasons behind why recent polling shows it is increasingly unpopular for American businesses to take a political stance.
Les mer »
Why more Americans are working into their 70s - Best New Ideas in MoneyEmployment rates among seniors are on the rise. But pocketbook imperatives aren't the only reason. Now, more older workers are practicing unretirement.
Les mer »
Novavax updated Covid vaccine wins FDA, CDC backing, paving way to reach Americans within daysHealth officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and Moderna.
Les mer »
As Fed hesitates, Americans heading for more inflationFederal Reserve Chairman Jerome Powell is trying to thread a needle — tame inflation that peaked at 9.1% in June 2022 while avoiding an economic slowdown. He has chosen to punt — in September, the Fed policymaking committee he leads left interest rates unchanged.
Les mer »